Mark L. McBride

1.6k total citations
33 papers, 1.1k citations indexed

About

Mark L. McBride is a scholar working on Cardiology and Cardiovascular Medicine, Virology and Family Practice. According to data from OpenAlex, Mark L. McBride has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 3 papers in Virology and 3 papers in Family Practice. Recurrent topics in Mark L. McBride's work include Heart Failure Treatment and Management (20 papers), Cardiac pacing and defibrillation studies (15 papers) and Cardiovascular Function and Risk Factors (5 papers). Mark L. McBride is often cited by papers focused on Heart Failure Treatment and Management (20 papers), Cardiac pacing and defibrillation studies (15 papers) and Cardiovascular Function and Risk Factors (5 papers). Mark L. McBride collaborates with scholars based in United States, Australia and Italy. Mark L. McBride's co-authors include Anne B. Curtis, Clyde W. Yancy, Mandeep R. Mehra, Gregg C. Fonarow, Dwight Reynolds, J. Thomas Heywood, Nancy M. Albert, Mary Norine Walsh, Christopher M. O’Connor and Mihai Gheorghiade and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of the American Society of Nephrology.

In The Last Decade

Mark L. McBride

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark L. McBride United States	18	950	133	113	84	75	33	1.1k
Lívia Adams Goldraich Brazil	14	462 0.5×	182 1.4×	142 1.3×	25 0.3×	27 0.4×	69	786
Martin Stagmo Sweden	13	506 0.5×	191 1.4×	104 0.9×	31 0.4×	48 0.6×	32	715
Jennifer T. Thibodeau United States	20	743 0.8×	371 2.8×	146 1.3×	29 0.3×	31 0.4×	57	1.2k
K Meeter Netherlands	10	328 0.3×	186 1.4×	33 0.3×	23 0.3×	42 0.6×	18	614
Anekwe Onwuanyi United States	14	273 0.3×	122 0.9×	56 0.5×	18 0.2×	35 0.5×	45	539
Prafulla Kerkar India	15	736 0.8×	261 2.0×	184 1.6×	22 0.3×	63 0.8×	78	1.1k
Dmitry Abramov United States	15	416 0.4×	189 1.4×	51 0.5×	6 0.1×	30 0.4×	110	736
Jamie Rankin Australia	12	342 0.4×	128 1.0×	38 0.3×	35 0.4×	42 0.6×	42	455
Michael W. Cullen United States	16	390 0.4×	191 1.4×	87 0.8×	17 0.2×	61 0.8×	43	735
William Mcclellan United States	9	258 0.3×	31 0.2×	111 1.0×	8 0.1×	67 0.9×	10	712

Countries citing papers authored by Mark L. McBride

Since Specialization

Citations

This map shows the geographic impact of Mark L. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. McBride more than expected).

Fields of papers citing papers by Mark L. McBride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. McBride. The network helps show where Mark L. McBride may publish in the future.

Co-authorship network of co-authors of Mark L. McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. McBride. A scholar is included among the top collaborators of Mark L. McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. McBride. Mark L. McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rutman, Howard, Mark L. McBride, Eric Grigsby, et al.. (2024). EFFICACY OF XT-150, A NOVEL NON-VIRAL GENE THERAPY DELIVERING IL-10v, ON MODERATE TO SEVERE PAIN DUE TO KNEE OSTEOARTHRITIS: PATIENT SUBGROUP ANALYSIS. Osteoarthritis and Cartilage. 32. S41–S41. 5 indexed citations

Eichenfield, Lawrence F., Elaine C. Siegfried, Pearl Kwong, et al.. (2021). Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum. American Journal of Clinical Dermatology. 22(2). 257–265. 9 indexed citations

Anand, R., Richard D. Hartman, V. Lucini, et al.. (2015). Long-term efficacy of safinamide as add-on to levodopa in Parkinson’s disease fluctuating patients: results from a 2-year placebo-controlled trial. Journal of the Neurological Sciences. 357. e276–e276.

Tilden, Dominic, et al.. (2014). Cost Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension – an Australian Payer Perspective. Value in Health. 17(7). A762–A762. 3 indexed citations

Wilcox, Jane E., Gregg C. Fonarow, Clyde W. Yancy, et al.. (2011). Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF. American Heart Journal. 163(1). 49–56.e2. 122 indexed citations

Gheorghiade, Mihai, Nancy M. Albert, Anne B. Curtis, et al.. (2011). Medication Dosing in Outpatients With Heart Failure After Implementation of a Practice‐Based Performance Improvement Intervention: Findings From IMPROVE HF. Congestive Heart Failure. 18(1). 9–17. 59 indexed citations

O’Connor, Christopher M., Nancy M. Albert, Anne B. Curtis, et al.. (2011). Patient and Practice Factors Associated With Improvement in Use of Guideline-Recommended Therapies for Outpatients With Heart Failure (from the IMPROVE HF Trial). The American Journal of Cardiology. 107(2). 250–258. 5 indexed citations

Albert, Nancy M., Gregg C. Fonarow, Clyde W. Yancy, et al.. (2010). Outpatient Cardiology Practices With Advanced Practice Nurses and Physician Assistants Provide Similar Delivery of Recommended Therapies (Findings from IMPROVE HF). The American Journal of Cardiology. 105(12). 1773–1779. 19 indexed citations

Walsh, Mary Norine, Gregg C. Fonarow, Nancy M. Albert, et al.. (2010). EQUITABLE IMPROVEMENT FOR WOMEN AND MEN IN THE USE OF GUIDELINE-RECOMMENDED THERAPIES FOR HEART FAILURE: FINDINGS FROM IMPROVE HF. Journal of the American College of Cardiology. 55(10). A142.E1330–A142.E1330. 2 indexed citations

10.

Heywood, J. Thomas, Gregg C. Fonarow, Clyde W. Yancy, et al.. (2010). Influence of Renal Function on the Use of Guideline-Recommended Therapies for Patients With Heart Failure. The American Journal of Cardiology. 105(8). 1140–1146. 40 indexed citations

11.

Walsh, Mary Norine, Clyde W. Yancy, Nancy M. Albert, et al.. (2010). Electronic health records and quality of care for heart failure. American Heart Journal. 159(4). 635–642.e1. 25 indexed citations

12.

Walsh, Mary Norine, Clyde W. Yancy, Nancy M. Albert, et al.. (2010). Equitable Improvement for Women and Men in the Use of Guideline-Recommended Therapies for Heart Failure: Findings From IMPROVE HF. Journal of Cardiac Failure. 16(12). 940–949. 17 indexed citations

13.

Albert, Nancy M., Mihai Gheorghiade, J. Thomas Heywood, et al.. (2010). Influence of Race on Improvements in Use of Guideline Recommended Heart Failure Therapies: Findings from IMPROVE HF. Journal of Cardiac Failure. 16(8). S70–S70. 1 indexed citations

14.

Fonarow, Gregg C., Nancy M. Albert, Anne B. Curtis, et al.. (2010). Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices. Circulation. 122(6). 585–596. 302 indexed citations

15.

Yancy, Clyde W., Gregg C. Fonarow, Nancy M. Albert, et al.. (2009). Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. American Heart Journal. 157(4). 754–762.e2. 82 indexed citations

16.

Curtis, Anne B., Clyde W. Yancy, Nancy M. Albert, et al.. (2009). Cardiac resynchronization therapy utilization for heart failure: Findings from IMPROVE HF. American Heart Journal. 158(6). 956–964. 40 indexed citations

17.

Mehra, Mandeep R., Clyde W. Yancy, Nancy M. Albert, et al.. (2009). Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post–myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 6(12). 1727–1734. 34 indexed citations

18.

Fonarow, Gregg C., Clyde W. Yancy, Nancy M. Albert, et al.. (2009). Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of IMPROVE HF. Journal of Cardiac Failure. 15(9). 813–813. 1 indexed citations

19.

Fonarow, Gregg C., Nancy M. Albert, Wendy Gattis Stough, et al.. (2007). Heart Failure Quality of Care in the Outpatient Cardiology Practice Setting: A Report from IMPROVE HF. Journal of Cardiac Failure. 13(6). S172–S172. 1 indexed citations

20.

McBride, Mark L., et al.. (1990). Quality of life after heart transplantation in patients assigned to double- or triple-drug therapy.. PubMed. 9(4). 392–6. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact